Trinity Biotech TRIB 深 沪
等待开盘 08-10 09:30:00 美东时间
12.43
+0.790
+6.79%
华盛通- 最 高12.5651
- 今 开11.79
- 成交量 2.04万股
- 最 低 10.54
- 昨 收 11.64
- 总市值 47.37万
- 52周最高 14.17
- 市盈率 静 34.03
- 换手率 0.05%
- 52周最低 0.282
- 委 比 53.60%
- 总股本 3.81万
- 历史最高 27.62
- 量 比 1.35
- 振 幅 17.40%
- 历史最低 0.2601
- 每 手 1
- 风险率 2.01%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Trinity Biotech Announces ADS Ratio Change From One ADS Representing 20 Ordinary Shares To One ADS Representing 600 Ordinary Shares
For Trinity Biotech Plc ADS holders, the change in the ADS ratio will have the same effect as a one for-thirty reverse ADS split and is intended to i) enable the Company to regain compliance with the $1.00 Nasdaq
07-22 19:19
Trinity Biotech Terminates Standby Equity Purchase Agreement With YA II
Trinity Biotech plc (NASDAQ:TRIB), a commercial stage biotechnology company focused on human diagnostics and the development of innovative solutions addressing unmet clinical and industrial needs, today announced that
06-30 03:17
Trinity Biotech Launches $4,352,314 At-The-Market ADS Offering Through Lucid Capital
TRINITY BIOTECH PLC Up to $4,352,314 American Depositary Shares representing Ordinary Shares We have entered into an At the Market Offering Agreement (the "ATM Sales Agreement"), with Lucid Capital
06-13 04:21
Trinity Biotech Receives Nasdaq Noncompliance Notice
Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, received notice on February 11, 2026 from the
02-14 06:12
US Stocks Mixed; GDP Growth Tops Expectations
U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining around...
2025-12-23 23:01
Why Is Trinity Biotech Stock Soaring Tuesday?
Trinity Biotech (NASDAQ: TRIB) surged on Tuesday due to a large HIV testing order and balance-sheet restructuring.
2025-12-23 22:59
Trinity Biotech Promotes Paul Murphy To Interim CFO
Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced it has received an order for 9
2025-12-23 20:38
Trinity Biotech Awarded 9M Order For Its TrinScreen HIV Flagship HIV Screening Product
Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced it has received an order for 9
2025-12-23 20:34
Trinity Biotech Expands Global Rollout Of Next-Generation HbA1c Column System
Company advances its mission to deliver next-generation diabetes management solutions and expand global market penetrationNext-generation column technology enhances efficiency, expands recurring revenue potential, and
2025-12-15 22:19
Trinity Biotech Provides An Update On The Continued Development Of Its Continuous Glucose Monitor Technology; Says Recent Testing Of This Patented Process Has Confirmed Its Effectiveness In Improving The Performance Of Trinity Biotech's Glucose Biosensor
Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today provided an update on the continued
2024-09-10 04:26
